Tennessee Oncology-Nashville/Sarah Cannon Research Institute

Nashville, Tennessee 37203

1 studies enrolling now · 9 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Solid Tumors, Breast Neoplasms, Carcinoma, Non-Small- Cell Lung, Endometrial Cancer, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Mutations Breast Neoplasms

Studies at this site

• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] — Completed
• Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma — Stopped early
• A Study of SEA-CD40 Given With Other Drugs in Cancers — Completed
• A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors — Stopped early
• Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer — Completed
• Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer — Completed
• A Safety Study of SGN-LIV1A in Breast Cancer Patients — Completed